We are live on ! Find out more
CCM

Callodine Capital Management Portfolio holdings

AUM $1.43B
1-Year Est. Return 8.74%
This Fund
S&P 500
This Quarter Est. Return
-12.03%
1 Year Est. Return
+8.74%
3 Year Est. Return
+43.6%
5 Year Est. Return
+40.63%
10 Year Est. Return
–
AUM
$337M
AUM Growth
+$26M
Cap. Flow
+$70.1M
Cap. Flow %
20.76%
Top 10 Hldgs %
41.52%
Holding
54
New
11
Increased
24
Reduced
11
Closed
4

Top Buys

Rank Stock Value
1
MRK icon
Merck
MRK
+$12.4M
2
BBDC icon
Barings BDC
BBDC
+$9.14M
3
SNY icon
Sanofi
SNY
+$8.86M
4
BXSL icon
Blackstone Secured Lending
BXSL
+$8.47M
5
KKR icon
KKR & Co
KKR
+$8.13M

Top Sells

Rank Stock Value
1
BMY icon
Bristol-Myers Squibb
BMY
+$13.9M
2
LPLA icon
LPL Financial
LPLA
+$4.57M
3
MO icon
Altria Group
MO
+$4.27M
4
TMUS icon
T-Mobile US
TMUS
+$3.91M
5
CEG icon
Constellation Energy
CEG
+$3.65M

Sector Composition

Rank Sector Weight
1 Financials 48.54%
2 Healthcare 11.66%
3 Real Estate 10.11%
4 Consumer Discretionary 9.13%
5 Communication Services 5.06%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CEG icon
51
Constellation Energy
CEG
$95.6B
– –
-64,897
Closed -$3.65M
DTM icon
52
DT Midstream
DTM
$13.4B
– –
-60,000
Closed -$3.26M
LMT icon
53
Lockheed Martin
LMT
$136B
– –
-2,500
Closed -$1.1M
LPLA icon
54
LPL Financial
LPLA
$28.6B
– –
-25,000
Closed -$4.57M
1 2
3

Similar funds

TS
Triglav Skladi Ljubljana, Slovenia $1.43B AUM 39.24% 1-Year Est. Return
SCA
Stonebridge Capital Advisors St Paul, Minnesota $1.43B AUM 21.98% 1-Year Est. Return
SC
Styrax Capital New York $1.43B AUM 50.63% 1-Year Est. Return
KGI
Kopernik Global Investors Tampa, Florida $1.43B AUM 63.57% 1-Year Est. Return
WIM
Weitz Investment Management Omaha, Nebraska $1.43B AUM 0.51% 1-Year Est. Return
APCM
Alaska Permanent Capital Management Anchorage, Alaska $1.43B AUM 13.12% 1-Year Est. Return
KCMH
Kontiki Capital Management (HK) Hong Kong $1.43B AUM 9.81% 1-Year Est. Return
LCG
Luxor Capital Group New York $1.43B AUM 30.88% 1-Year Est. Return

Callodine Capital Management's Q2 2022 Portfolio in Review

As of Q2 2022, Callodine Capital Management held 54 positions worth $337M, up 8.3% from $311M the previous quarter. Its ten largest holdings account for 42% of the portfolio.

Callodine Capital Management deployed $70.1M of net new capital in Q2 2022, opening 11 new positions and adding to 24 existing holdings. Its largest new stake was Sanofi: 166,935 shares worth $8.35M.

By sector, the portfolio is most concentrated in Financials at 49% of assets, up from 45% a quarter earlier, followed by Healthcare and Real Estate.

On the sell side, the largest reduction was Bristol-Myers Squibb, an estimated $13.9M trimmed.

  • Callodine Capital Management's largest Q2 2022 buy was Sanofi: 166,935 shares worth $8.35M.
  • Callodine Capital Management added most to Merck in Q2 2022, an estimated $12.4M increase.
  • Callodine Capital Management's biggest Q2 2022 reduction was Bristol-Myers Squibb, cutting an estimated $13.9M.
  • Callodine Capital Management fully exited LPL Financial in Q2 2022, selling an estimated $4.57M.
  • Callodine Capital Management's ten largest holdings make up 42% of its $337M portfolio in Q2 2022.
  • Callodine Capital Management opened 11 new positions and closed 4 in Q2 2022.
  • Callodine Capital Management's portfolio value rose 8.3% quarter-over-quarter to $337M.

Based on Callodine Capital Management's 13F filing for Q2 2022, filed 12 Aug 2022.